After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...
2d
News-Medical.Net on MSNGLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...
A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.
Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...
Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...
A study comparing GLP-1 users to others on antidiabetic drugs showed no added risk once confounders were accounted for.
section. Victoza contains the active ingredient liraglutide. It belongs to a group of diabetes drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Victoza is a brand-name medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results